Galaxy Diagnostics and Virginia Tech Unite to Advance Testing for Lyme Disease By Nicole Danielle Bell, CEO of Galaxy Diagnostics and author of What Lurks in the Woods When a Test Fails a Patient When diagnostics fail patients, the consequences are real. I’ve lived it. My husband tested negative using the current standard-of-care test for… Continue reading Two LymeX Innovators, One Mission: Better Answers for Patients
Galaxy Diagnostics and Virginia Tech Unite to Strengthen Direct Detection Approaches for Lyme Disease By Nicole Danielle Bell, CEO of Galaxy Diagnostics and author of What Lurks in the Woods The Diagnostic Uncertainty Clinicians Face Clinicians evaluating patients with suspected tick-borne disease routinely manage diagnostic uncertainty. Prior exposure, immune variability, and timing-dependent antibody responses can… Continue reading Two LymeX Innovators, One Mission: Advancing Reliable Lyme Diagnostics
Making Sense of Lyme Research – What Does the Science Say? When I finally realized that my husband’s early-onset Alzheimer’s was caused by Lyme disease and other co-infections, I tried to use my engineering background to make sense of it all. I very quickly found myself lost. An excerpt from my memoir about our… Continue reading Making sense of Lyme Research – What does the Science say?
